AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma
Authors: Jeronimo, C Usadel, H Henrique, R Oliveira, J Lopes, C Nelson, WG Sidransky, D
Citation: C. Jeronimo et al., Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma, J NAT CANC, 93(22), 2001, pp. 1747-1752
Ribbed mussel nitrogen isotope signatures reflect nitrogen sources in coastal salt marshes
Authors: McKinney, RA Nelson, WG Charpentier, MA Wigand, C
Citation: Ra. Mckinney et al., Ribbed mussel nitrogen isotope signatures reflect nitrogen sources in coastal salt marshes, ECOL APPL, 11(1), 2001, pp. 203-214
Relationships among total lipid, lipid classes, and polychlorinated biphenyl concentrations in two indigenous populations of ribbed mussels (Geukensia demissa) over an annual cycle
Authors: Bergen, BJ Nelson, WG Quinn, JG Jayaraman, S
Citation: Bj. Bergen et al., Relationships among total lipid, lipid classes, and polychlorinated biphenyl concentrations in two indigenous populations of ribbed mussels (Geukensia demissa) over an annual cycle, ENV TOX CH, 20(3), 2001, pp. 575-581
The molecular pathogenesis of prostate cancer - Focus on the earliest steps
Authors: Nelson, WG DeMarzo, AM DeWeese, TL
Citation: Wg. Nelson et al., The molecular pathogenesis of prostate cancer - Focus on the earliest steps, EUR UROL, 39, 2001, pp. 8-11
GSTAI expression in normal, preneoplastic, and neoplastic human prostate tissue
Authors: Parsons, JK Nelson, CP Gage, WR Nelson, WG Kensler, TW De Marzo, AM
Citation: Jk. Parsons et al., GSTAI expression in normal, preneoplastic, and neoplastic human prostate tissue, PROSTATE, 49(1), 2001, pp. 30-37
p63 protein expression is rare in prostate adenocarcinoma: Implications for cancer diagnosis and carcinogenesis
Authors: Parsons, JK Gage, WR Nelson, WG De Marzo, AM
Citation: Jk. Parsons et al., p63 protein expression is rare in prostate adenocarcinoma: Implications for cancer diagnosis and carcinogenesis, UROLOGY, 58(4), 2001, pp. 619-624
New clinical trial strategies for prostate cancer prevention - Introduction
Authors: Lieberman, R Nelson, WG
Citation: R. Lieberman et Wg. Nelson, New clinical trial strategies for prostate cancer prevention - Introduction, UROLOGY, 57(4A), 2001, pp. 1-3
Executive summary of the National Cancer Institute Workshop: Highlights and recommendations
Authors: Lieberman, R Nelson, WG Sakr, WA Meysken, FL Klein, EA Wilding, G Partin, AW Lee, JJ Lippman, SM
Citation: R. Lieberman et al., Executive summary of the National Cancer Institute Workshop: Highlights and recommendations, UROLOGY, 57(4A), 2001, pp. 4-27
The molecular pathogenesis of prostate cancer: Implications for prostate cancer prevention
Authors: Nelson, WG De Marzo, AM DeWeese, TL
Citation: Wg. Nelson et al., The molecular pathogenesis of prostate cancer: Implications for prostate cancer prevention, UROLOGY, 57(4A), 2001, pp. 39-45
Prostate cancer prevention agent development: Criteria and pipeline for candidate chemoprevention agents
Authors: Nelson, WG Wilding, G
Citation: Wg. Nelson et G. Wilding, Prostate cancer prevention agent development: Criteria and pipeline for candidate chemoprevention agents, UROLOGY, 57(4A), 2001, pp. 56-63
New concepts in the pathology of prostatic epithelial carcinogenesis
Authors: De Marzo, AM Putzi, MJ Nelson, WG
Citation: Am. De Marzo et al., New concepts in the pathology of prostatic epithelial carcinogenesis, UROLOGY, 57(4A), 2001, pp. 103-114
Plasma selenium level before diagnosis and the risk of prostate cancer development
Authors: Brooks, JD Metter, EJ Chan, DW Sokoll, LJ Landis, P Nelson, WG Muller, D Andres, R Carter, HB
Citation: Jd. Brooks et al., Plasma selenium level before diagnosis and the risk of prostate cancer development, J UROL, 166(6), 2001, pp. 2034-2038
A phase I trial of CV706, a replication-competent, PSA selective oncolyticadenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy
Authors: DeWeese, TL van der Poel, H Li, SD Mikhak, B Drew, R Goemann, M Hamper, U DeJong, R Detorie, N Rodriguez, R Haulk, T DeMarzo, AM Piantadosi, S Yu, DC Chen, Y Henderson, DR Carducci, MA Nelson, WG Simons, JW
Citation: Tl. Deweese et al., A phase I trial of CV706, a replication-competent, PSA selective oncolyticadenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy, CANCER RES, 61(20), 2001, pp. 7464-7472
Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells
Authors: Yang, XW Phillips, DL Ferguson, AT Nelson, WG Herman, JG Davidson, NE
Citation: Xw. Yang et al., Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells, CANCER RES, 61(19), 2001, pp. 7025-7029
Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1
Authors: Nelson, CP Kidd, LCR Sauvageot, J Isaacs, WB De Marzo, AM Groopman, JD Nelson, WG Kensler, TW
Citation: Cp. Nelson et al., Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1, CANCER RES, 61(1), 2001, pp. 103-109
GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells
Authors: Lin, XH Tascilar, M Lee, WH Vles, WJ Lee, BH Veeraswamy, R Asgari, K Freije, D van Rees, B Gage, WR Bova, GS Isaacs, WB Brooks, JD DeWeese, TL De Marzo, AM Nelson, WG
Citation: Xh. Lin et al., GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells, AM J PATH, 159(5), 2001, pp. 1815-1826
Chemoprevention of prostate cancer
Authors: Brooks, JD Nelson, WG
Citation: Jd. Brooks et Wg. Nelson, Chemoprevention of prostate cancer, CONT CANC R, 2001, pp. 365-375
Methylation of the neutral endopeptidase gene promoter in human prostate cancers
Authors: Usmani, BA Shen, RQ Janeczko, M Papandreou, CN Lee, WH Nelson, WG Nelson, JB Nanus, DM
Citation: Ba. Usmani et al., Methylation of the neutral endopeptidase gene promoter in human prostate cancers, CLIN CANC R, 6(5), 2000, pp. 1664-1670
No association between the I105V polymorphism of the glutathione S-transferase P1 gene (GSTP1) and prostate cancer risk: A prospective study
Authors: Shepard, TF Platz, EA Kantoff, PW Nelson, WG Isaacs, WB Freije, D Febbo, PG Stampfer, MJ Giovannucci, E
Citation: Tf. Shepard et al., No association between the I105V polymorphism of the glutathione S-transferase P1 gene (GSTP1) and prostate cancer risk: A prospective study, CANC EPID B, 9(11), 2000, pp. 1267-1268
Doxorubicin-resistant variants of human prostate cancer cell lines DU 145,PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity
Authors: David-Beabes, GL Overman, MJ Petrofski, JA Campbell, PA De Marzo, AM Nelson, WG
Citation: Gl. David-beabes et al., Doxorubicin-resistant variants of human prostate cancer cell lines DU 145,PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity, INT J ONCOL, 17(6), 2000, pp. 1077-1086
GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas
Authors: Tchou, JC Lin, XH Freije, D Isaacs, WB Brooks, JD Rashid, A De Marzo, AM Kanai, Y Hirohashi, S Nelson, WG
Citation: Jc. Tchou et al., GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas, INT J ONCOL, 16(4), 2000, pp. 663-676
Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies
Authors: Nelson, WG Simons, JW Mikhak, B Chang, JF DeMarzo, AM Carducci, MA Kim, M Weber, CE Baccala, AA Goeman, MA Clift, SM Ando, DG Levitsky, HI Cohen, LK Sanda, MG Mulligan, RC Partin, AW Carter, HB Piantadosi, S Marshall, FF
Citation: Wg. Nelson et al., Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies, CANC CHEMOT, 46, 2000, pp. S67-S72
Expression of DNA methyl-transferase (DMT) and the cell cycle in human breast cancer cells
Authors: Nass, SJ Ferguson, AT El-Ashry, D Nelson, WG Davidson, NE
Citation: Sj. Nass et al., Expression of DNA methyl-transferase (DMT) and the cell cycle in human breast cancer cells, ONCOGENE, 18(52), 1999, pp. 7453-7461
Prostate cancer vaccines: Current status
Authors: Hwang, LC Fein, S Levitsky, H Nelson, WG
Citation: Lc. Hwang et al., Prostate cancer vaccines: Current status, SEMIN ONCOL, 26(2), 1999, pp. 192-201
New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia
Authors: De Marzo, AM Coffey, DS Nelson, WG
Citation: Am. De Marzo et al., New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia, UROLOGY, 53(3), 1999, pp. 29-40
Risultati: 1-25 | 26-31